STOCK TITAN
  1. Home
  2. Sec-filings
  3. RIVN
  4. [Form 4] Rivian Automotive, Inc. / DE Insider Trading Activity

Rivian Insider Sale: Scaringe Disposes 17,450 RIVN Shares at $15.14

Filing Impact
(High)
Filing Sentiment
(Negative)
Form Type
4

Rhea-AI Filing Summary

Robert J. Scaringe, Chief Executive Officer and Director of Rivian Automotive, Inc. (RIVN), reported a sale of 17,450 shares of Class A common stock on 09/30/2025 at a weighted average price of $15.1396 per share. The filing states the sale was effected automatically under a previously disclosed Rule 10b5-1 trading plan adopted on 03/14/2025 and amended on 06/11/2025. The sale prices ranged from $15.01 to $15.50 across multiple transactions.

Following the reported transaction, the reporting person directly beneficially owns 1,298,755 shares, indirectly owns 2,297 shares through an LLC, and indirectly owns 2,632,766 shares through a trust. The Form 4 was signed by an attorney-in-fact on 10/02/2025.

Positive

  • Sale executed under a documented Rule 10b5-1 plan adopted 03/14/2025 and amended 06/11/2025, indicating prearranged trading
  • Filing discloses weighted average price and price range ($15.1396; $15.01–$15.50), and offers to provide per-price detail on request, enhancing transparency
  • Detailed post-transaction ownership figures provided: 1,298,755 direct; 2,297 indirect by LLC; 2,632,766 indirect by trust

Negative

  • Insider sale of 17,450 shares on 09/30/2025 (potentially dilutive to insider ownership position)
  • Sale reduces direct holdings although the filing does not state rationale beyond the 10b5-1 plan

Insights

TL;DR: CEO executed an automatic plan sale of 17,450 shares under a documented 10b5-1 plan.

The Form 4 discloses a rule-compliant sale executed on 09/30/2025 via a 10b5-1 trading plan adopted 03/14/2025 and amended 06/11/2025. The disclosure lists the weighted average sale price of $15.1396 with transaction prices between $15.01 and $15.50, and promises to provide per-price detail on request. Such timely Form 4 reporting supports transparency around insider transactions.

Actionable detail: the specific transaction date and the plan adoption/amendment dates are disclosed in the filing.

Insider Scaringe Robert J
Role Chief Executive Officer
Sold 17,450 shs ($264K)
Type Security Shares Price Value
Sale Class A Common Stock 17,450 $15.1396 $264K
holding Class A Common Stock -- -- --
holding Class A Common Stock -- -- --
Holdings After Transaction: Class A Common Stock — 1,298,755 shares (Direct); Class A Common Stock — 2,297 shares (Indirect, By LLC)
Footnotes (1)
  1. The sale reported in this transaction was effected automatically pursuant to a previously disclosed Rule 10b5-1 trading plan adopted on March 14, 2025 and amended on June 11, 2025, as disclosed in the Issuer's Quarterly Report on Form 10-Q for each such quarter. The price reported is a weighted average sale price. The shares were sold in multiple transactions at prices ranging from $15.01 to $15.50, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the SEC, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote.
Form 4 Insider Transactions: What Each Field Means →
SEC Form 4
FORM 4 UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940
OMB APPROVAL
OMB Number: 3235-0287
Estimated average burden
hours per response: 0.5
Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).
1. Name and Address of Reporting Person*
Scaringe Robert J
(Last) (First) (Middle)
C/O RIVIAN AUTOMOTIVE, INC.
14600 MYFORD ROAD
(Street)
IRVINE CA 92606
(City) (State) (Zip)
2. Issuer Name and Ticker or Trading Symbol
Rivian Automotive, Inc. / DE [ RIVN ] 		5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)
X Director 10% Owner
X Officer (give title below) Other (specify below)
Chief Executive Officer
3. Date of Earliest Transaction (Month/Day/Year)
09/30/2025
4. If Amendment, Date of Original Filed (Month/Day/Year)
 6. Individual or Joint/Group Filing (Check Applicable Line)
X Form filed by One Reporting Person
Form filed by More than One Reporting Person
Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3) 2. Transaction Date (Month/Day/Year) 2A. Deemed Execution Date, if any (Month/Day/Year) 3. Transaction Code (Instr. 8) 4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5) 5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4) 6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4) 7. Nature of Indirect Beneficial Ownership (Instr. 4)
Code V Amount (A) or (D) Price
Class A Common Stock 09/30/2025 S(1) 17,450 D $15.1396(2) 1,298,755 D
Class A Common Stock 2,297 I By LLC
Class A Common Stock 2,632,766 I By Trust
Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned
(e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3) 2. Conversion or Exercise Price of Derivative Security 3. Transaction Date (Month/Day/Year) 3A. Deemed Execution Date, if any (Month/Day/Year) 4. Transaction Code (Instr. 8) 5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5) 6. Date Exercisable and Expiration Date (Month/Day/Year) 7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4) 8. Price of Derivative Security (Instr. 5) 9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4) 10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4) 11. Nature of Indirect Beneficial Ownership (Instr. 4)
Code V (A) (D) Date Exercisable Expiration Date Title Amount or Number of Shares
Explanation of Responses:
1. The sale reported in this transaction was effected automatically pursuant to a previously disclosed Rule 10b5-1 trading plan adopted on March 14, 2025 and amended on June 11, 2025, as disclosed in the Issuer's Quarterly Report on Form 10-Q for each such quarter.
2. The price reported is a weighted average sale price. The shares were sold in multiple transactions at prices ranging from $15.01 to $15.50, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the SEC, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote.
Remarks:
/s/ Jamie Chung, Attorney-in-Fact 10/02/2025
** Signature of Reporting Person Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.

Source: View Original Filing on SEC EDGAR

FAQ

What did RIVN CEO Robert Scaringe report on Form 4?

The Form 4 reports a sale of 17,450 Class A shares on 09/30/2025 at a weighted average price of $15.1396 under a Rule 10b5-1 plan.

Was the sale part of a prearranged trading plan for RIVN insider activity?

Yes. The sale was effected automatically under a Rule 10b5-1 trading plan adopted on 03/14/2025 and amended on 06/11/2025.

How many RIVN shares does Robert Scaringe beneficially own after the sale?

Following the reported transaction he beneficially owns 1,298,755 shares directly, 2,297 indirectly via an LLC, and 2,632,766 indirectly via a trust.

What price range did the RIVN shares sell within?

The shares were sold in multiple transactions at prices ranging from $15.01 to $15.50.

Who signed the Form 4 filing for Robert Scaringe?

The Form 4 was signed by an attorney-in-fact, Jamie Chung, on 10/02/2025.